Acorda Therapeutics, Inc. (ACOR)
(Delayed Data from NSDQ)
$11.74 USD
+1.16 (10.96%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.74 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ACOR]
Reports for Purchase
Showing records 361 - 380 ( 440 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Feb. 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Feb. 7
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan. 24
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan. 24
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan. 17
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov. 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
New and Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week Ending May 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C